March 2017

Feature

Positioning CAR-T Therapy Into Clinical Pathways for Non-Hodgkin B-Cell Lymphoma and Beyond

03/23/2017

Abstract: Enthusiasm for immunotherapy has spread throughout the oncology community in recent years, as therapies harnessing the body’s ability to fight cancers have offered the potential for remission and even cure...

...

03/23/2017

Journal of Clinical Pathways

Feature

Research Reports

Clinical Pathways: A Current Snapshot, and the Journey Ahead

03/15/2017

Amy Schroeder , RPh;

03/15/2017

Journal of Clinical Pathways

Column

Clinical Pathways GPS

Developing Balanced Clinical Pathways Through Individualized Care

03/15/2017

Terri L. Schieder , RN, MS, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Clinical pathways should address all three aspects of the Triple Aim, but the aim of improving population health often is prioritized at the expense of improving the patient experience of care and reducing the cost...

...

03/15/2017

Journal of Clinical Pathways

Pharma Insights

The Role of Payers in Antibiotic Stewardship: Facilitating Transitions of Care for Patients With Active Infection

03/15/2017

Jeremy Schafer , PharmD, MBA;

All members of the health care community must play a role in antimicrobial stewardship. The payer role is to monitor appropriate antibiotic use, encourage low-cost options, and help to facilitate the transition of...

All...

03/15/2017

Journal of Clinical Pathways

Insights

Interview

The Potential Impact of Clinical Pathways for Bariatric Surgery

03/15/2017

JCP Editors

Obesity has reached a crisis point in the United States, and is now regularly classified as an epidemic.1 The proportion of obese adults now comprises one-third of the US population, according to data from the...

...

03/15/2017

Journal of Clinical Pathways

Interview

The Ethical Implications of Rapid Learning Systems in Oncology

03/15/2017

JCP Editors

Health care providers and research scientists frequently utilize emerging technology to enhance their ability to study diseases and develop effective treatment. A major area of growth in medicine has surrounded the...

...

03/15/2017

Journal of Clinical Pathways

News

Conference Coverage

ASCO Cancer Survivorship Summit

03/15/2017

JCP Editors

Cancer survivors are living longer than ever. Approximately 15.5 million cancer survivors are currently alive in the United States, according to a research report issued by the American Cancer Society—a number...

Cancer...

03/15/2017

Journal of Clinical Pathways

Conference Coverage

ASCO Gastrointestinal Cancers Symposium

03/15/2017

JCP Editors

Gastrointestinal (GI) malignancies remain a central focus of research and treatment within the oncology community. Colorectal cancer remains the third most common cancer diagnosed in the United States, as well as...

...

03/15/2017

Journal of Clinical Pathways

Department

Research in Review

Utilization of Hospice Services Vary by Individual Physician, Disease Type

03/15/2017

JCP Editors

Hospice referral for patients with advanced cancer continues to vary significantly by individual physician and treatment department, according to research published in Journal of Oncology Practice (published online...

...

03/15/2017

Journal of Clinical Pathways

Research in Review

Link Shown Between Unsolicited Patient Complaints, Increased Postsurgical Complications

03/15/2017

JCP Editors

Patients receiving surgery from a surgeon with a high number of unsolicited patient observations may be at greater risk for postoperative complications, according to research published in JAMA Surgery (published...

...

03/15/2017

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

March 2017

Feature

Column

Insights

News

Department

Current Issue

Special Reports

Subscribe

Volume 3

Specialties

Events

Year Round Education

HMP Global Products